Recombinant multi-species DUSP6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DUSP6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene product inactivates ERK2, is expressed in a variety of tissues with the highest levels in heart and pancreas, and unlike most other members of this family, is localized in the cytoplasm. Mutations in this gene have been associated with congenital hypogonadotropic hypogonadism. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014]
The Alternative Names of target: 1300019I03Rik,DUSP6,Dual specificity protein phosphatase 6,Dual specificity protein phosphatase PYST1,Dusp6,HH19,MKP-3,MKP-3),MKP3,Mitogen-activated protein kinase phosphatase 3 (MAP kinase phosphatase 3,Mkp3,PYST1
Go
to DUSP6 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP6253-Ag-1/ GM-Tg-hg-IP6253-Ag-2 | Human DUSP6 protein | Human |
| GM-Tg-rg-IP6253-Ag-1/ GM-Tg-rg-IP6253-Ag-2 | Rat DUSP6 protein | Rat |
| GM-Tg-mg-IP6253-Ag-1/ GM-Tg-mg-IP6253-Ag-2 | Mouse DUSP6 protein | Mouse |
| GM-Tg-cynog-IP6253-Ag-1/ GM-Tg-cynog-IP6253-Ag-2 | Cynomolgus/Rhesus macaque DUSP6 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP6253-Ag-1/ GM-Tg-felg-IP6253-Ag-2 | Feline DUSP6 protein | Feline |
| GM-Tg-cang-IP6253-Ag-1/ GM-Tg-cang-IP6253-Ag-2 | Canine DUSP6 protein | Canine |
| GM-Tg-bovg-IP6253-Ag-1/ GM-Tg-bovg-IP6253-Ag-2 | Bovine DUSP6 protein | Bovine |
| GM-Tg-equg-IP6253-Ag-1/ GM-Tg-equg-IP6253-Ag-2 | Equine DUSP6 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP6253-Ag-1/ GM-Tg-hg-IP6253-Ag-2;
GM-Tg-rg-IP6253-Ag-1/ GM-Tg-rg-IP6253-Ag-2;
GM-Tg-mg-IP6253-Ag-1/ GM-Tg-mg-IP6253-Ag-2; GM-Tg-cynog-IP6253-Ag-1/ GM-Tg-cynog-IP6253-Ag-2; GM-Tg-felg-IP6253-Ag-1/ GM-Tg-felg-IP6253-Ag-2; GM-Tg-cang-IP6253-Ag-1/ GM-Tg-cang-IP6253-Ag-2; GM-Tg-bovg-IP6253-Ag-1/ GM-Tg-bovg-IP6253-Ag-2; GM-Tg-equg-IP6253-Ag-1/ GM-Tg-equg-IP6253-Ag-2 |
| Products Name | DUSP6 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | DUSP6 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DUSP6 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.